B-Disease	0	10	Idiopathic
I-Disease	11	16	Acute
I-Disease	17	26	Exudative
I-Disease	27	39	Polymorphous
I-Disease	40	51	Vitelliform
I-Disease	52	63	Maculopathy
O	63	64	:
O	65	73	Clinical
O	74	82	Spectrum
O	83	86	and
O	87	97	Multimodal
O	98	105	Imaging
O	106	121	Characteristics
O	121	122	.

O	124	126	To
O	127	135	describe
O	136	144	clinical
O	145	153	findings
O	154	156	in
O	157	165	patients
O	166	170	with
B-Disease	171	176	acute
I-Disease	177	186	exudative
I-Disease	187	199	polymorphous
I-Disease	200	211	vitelliform
I-Disease	212	223	maculopathy
O	224	225	(
B-Disease	225	230	AEPVM
O	230	231	)
O	231	232	.

O	233	246	Retrospective
O	246	247	,
O	248	261	observational
O	261	262	,
O	263	274	multicenter
O	275	279	case
O	280	286	series
O	287	293	review
O	293	294	.

O	295	306	Consecutive
O	307	315	patients
O	316	325	diagnosed
O	326	330	with
B-Disease	331	341	idiopathic
I-Disease	342	347	AEPVM
O	347	348	.

O	349	355	Review
O	356	358	of
B-Diagnostic_tool	359	367	clinical
I-Diagnostic_tool	368	374	charts
O	374	375	,
B-Diagnostic_tool	376	386	multimodal
I-Diagnostic_tool	387	394	imaging
O	394	395	,
B-Characteristic	396	414	electrophysiologic
I-Characteristic	415	423	findings
O	423	424	,
O	425	428	and
B-Characteristic	429	436	genetic
I-Characteristic	437	445	findings
O	446	448	in
O	449	459	previously
O	460	471	unpublished
O	472	480	patients
O	481	484	and
O	485	491	review
O	492	494	of
O	495	498	the
O	499	509	literature
O	509	510	.

O	511	519	Clinical
O	520	528	features
O	529	531	of
B-Disease	532	542	idiopathic
I-Disease	543	548	AEPVM
O	549	552	and
O	553	565	differential
O	566	575	diagnosis
O	575	576	.

O	577	585	Eighteen
O	586	594	patients
O	595	596	(
B-Characteristic	596	599	age
I-Characteristic	600	605	range
I-Characteristic	605	606	,
I-Characteristic	607	609	21
I-Characteristic	609	610	-
I-Characteristic	610	612	74
I-Characteristic	613	618	years
O	618	619	)
O	620	624	with
O	625	632	typical
O	633	641	features
O	642	644	of
B-Disease	645	650	AEPVM
O	650	651	,
O	652	661	including
O	662	669	initial
B-Symptom	670	679	localized
I-Symptom	679	680	,
I-Symptom	681	687	serous
I-Symptom	688	699	detachments
I-Symptom	700	708	followed
I-Symptom	709	711	by
I-Symptom	712	715	the
I-Symptom	716	727	development
I-Symptom	728	730	of
I-Symptom	731	745	characteristic
I-Symptom	746	752	yellow
I-Symptom	752	753	-
I-Symptom	753	758	white
I-Symptom	759	767	deposits
I-Symptom	768	770	in
I-Symptom	771	774	the
I-Symptom	775	786	vitelliform
I-Symptom	787	792	space
O	792	793	.

O	794	798	Over
O	799	803	time
O	803	804	,
O	805	809	this
O	810	830	hyperautofluorescent
O	831	839	material
O	840	850	gravitated
O	851	857	within
O	858	861	the
O	862	868	larger
O	869	876	lesions
O	876	877	,
O	878	887	resulting
O	888	890	in
O	891	898	typical
O	899	910	curvilinear
O	911	919	deposits
O	920	934	characteristic
O	935	937	of
O	938	943	later
O	944	950	stages
O	950	951	.

O	952	960	Symptoms
O	961	964	and
O	965	973	clinical
O	974	982	findings
O	983	989	lasted
O	990	994	from
O	995	1000	weeks
O	1001	1003	to
O	1004	1011	several
O	1012	1017	years
O	1017	1018	.

O	1019	1023	Some
O	1024	1032	patients
O	1033	1039	showed
O	1040	1050	previously
O	1051	1062	undescribed
O	1063	1071	features
O	1072	1076	such
O	1077	1079	as
B-Symptom	1080	1091	fluorescein
I-Symptom	1091	1092	-
I-Symptom	1092	1100	negative
I-Symptom	1101	1113	intraretinal
I-Symptom	1114	1120	cystic
I-Symptom	1121	1128	changes
O	1128	1129	,
B-Symptom	1130	1139	choroidal
I-Symptom	1140	1158	neovascularization
O	1158	1159	,
B-Symptom	1160	1166	serous
I-Symptom	1167	1174	retinal
I-Symptom	1175	1185	elevations
I-Symptom	1186	1195	mimicking
I-Symptom	1196	1203	retinal
I-Symptom	1204	1209	folds
O	1209	1210	,
B-Symptom	1211	1220	increased
I-Symptom	1221	1230	choroidal
I-Symptom	1231	1240	thickness
O	1240	1241	,
B-Symptom	1242	1246	lack
I-Symptom	1247	1249	of
I-Symptom	1250	1255	rapid
I-Symptom	1256	1262	visual
I-Symptom	1263	1271	recovery
O	1271	1272	,
O	1273	1276	and
B-Symptom	1277	1287	recurrence
I-Symptom	1288	1293	years
I-Symptom	1294	1299	after
I-Symptom	1300	1308	complete
I-Symptom	1309	1319	resolution
I-Symptom	1320	1322	of
I-Symptom	1323	1330	initial
I-Symptom	1331	1345	manifestations
O	1345	1346	.

B-Disease	1347	1352	Acute
I-Disease	1353	1362	exudative
I-Disease	1363	1375	polymorphous
I-Disease	1376	1387	vitelliform
I-Disease	1388	1399	maculopathy
O	1400	1403	can
O	1404	1411	present
O	1412	1416	with
O	1417	1418	a
O	1419	1423	more
O	1424	1432	variable
O	1433	1440	natural
O	1441	1447	course
O	1448	1452	than
O	1453	1463	previously
O	1464	1473	described
O	1473	1474	.

B-Disease	1475	1489	Paraneoplastic
I-Disease	1490	1501	retinopathy
O	1502	1505	and
B-Disease	1506	1515	autosomal
I-Disease	1516	1525	recessive
I-Disease	1526	1542	bestrophinopathy
O	1543	1550	closely
O	1551	1559	resemble
B-Disease	1560	1565	AEPVM
O	1565	1566	,
O	1567	1580	necessitating
O	1581	1588	medical
O	1589	1592	and
O	1593	1603	hereditary
O	1604	1614	evaluation
O	1615	1617	to
O	1618	1625	exclude
O	1626	1631	these
O	1632	1640	clinical
O	1641	1654	possibilities
O	1654	1655	.

O	1656	1660	This
O	1661	1667	series
O	1668	1670	of
O	1671	1679	patients
O	1680	1684	with
B-Disease	1685	1690	AEPVM
O	1691	1698	expands
O	1699	1702	the
O	1703	1711	clinical
O	1712	1720	spectrum
O	1721	1723	of
O	1724	1727	the
O	1728	1736	disorder
O	1736	1737	,
O	1738	1747	including
B-Characteristic	1748	1760	demographics
O	1760	1761	,
B-Characteristic	1762	1770	clinical
I-Characteristic	1771	1785	manifestations
O	1785	1786	,
B-Characteristic	1787	1794	imaging
I-Characteristic	1795	1803	features
O	1803	1804	,
B-Characteristic	1805	1812	natural
I-Characteristic	1813	1819	course
O	1819	1820	,
O	1821	1824	and
B-Characteristic	1825	1831	visual
I-Characteristic	1832	1841	prognosis
O	1841	1842	.
